Feng et al.
FULL PAPER
Compounds 8a—8c were further treated with hy-
drochloric acid gas in ethyl ether to give compounds 9a
—9c.
Hz, 1H, Ar-H), 7.38 (dd, J=4.4, 8.0 Hz, 1H, Ar-H),
7.21 (s, 1H, Ar-H), 7.19 (s, 1H, Ar-H), 6.92 (s, 1H,
Ar-H), 2.18 (s, 3H, CH3); 13C NMR (CDCl3, 100 MHz)
δ: 156.3, 148.0, 147.1, 144.2, 139.5, 139.1 (2C), 132.0,
131.9, 131.8, 130.6, 127.4, 127.1, 126.6, 122.4, 110.+7,
17.4; HRMS calcd for C17H12BrCl2N5O2Na ([M+Na] )
489.9445, found 489.9444.
3-Bromo-N-(4-chloro-2-methyl-6-((methylamino)-
methyl)phenyl)-1-(3-chloropyridin-2-yl)-1H-pyrazole-
5-carboxamide hydrochloride (9a)
White solid,
quantitative yield, m.p. 168—170 ℃; 1H NMR (CDCl3,
400+MHz) δ: 10.80 (s, 1H, CONH), 9.19 (brs, 2H,
NH2 Cl- ), 8.52 (d, J=4.8 Hz, 1H, Ar-H), 8.21 (d, J=
8.4 Hz, 1H, Ar-H), 7.73 (s, 1H, Ar-H), 7.63 (dd, 1H,
J=4.8, 8.0 Hz, Ar-H), 7.57 (s, 1H, Ar-H), 7.48 (s, 1H,
Ar-H), 4.01 (t, J=5.8 Hz, 2H, CH2), 2.55 (t, J=5.0 Hz,
3H, CH3), 2.17 (s, 3H, Ar-CH3); 13C NMR (CDCl3, 100
MHz) δ: 155.9, 148.3, 147.2, 139.4, 138.9, 133.1, 131.7,
131.6, 130.8, 128.2, 128.1, 127.7, 126.6, 111.4, 47.1,
32.4, 17.8; HRMS calcd for C18H17BrCl2N5O ([M-Cl])+
467.9984, found 467.9988.
3-Bromo-N-(4-chloro-2-((Z)-methoxyiminometh-
yl)-6-methylphenyl)-1-(3-chloropyridin-2-yl)-1H-
pyrazole-5-carboxamide (10b) This compound was
prepared following the same procedure described for
compound 10a using methoxamine hydrochloride
instead of hydroxylamine hydrochloride. White solid,
1
yield 90%, m.p. 219—220 ℃; H NMR (CDCl3, 400
MHz) δ: 9.37 (s, 1H, CONH), 8.48 (d, J=4.0 Hz, 1H,
Ar-H), 8.05 (s, 1H, CH), 7.85 (d, J=8.0 Hz, 1H, Ar-H),
7.39 (dd, J=4.8, 8.0 Hz, 1H, Ar-H), 7.22 (s, 2H, Ar-H),
6.96 (s, 1H, Ar-H), 3.97 (s, 3H, OCH3), 2.20 (s, 3H,
Ar-CH3); 13C NMR (CDCl3, 100 MHz) δ: 155.7, 148.7,
148.1, 147.0, 139.3, 139.1, 137.6, 132.3, 132.0, 131.4,
128.8, 128.0, 127.8, 127.2, 125.8, 110.3, 62.6, 19+.0;
HRMS calcd for C18H14BrCl2N5O2Na ([M + Na] )
503.9595, found 503.9600.
3-Bromo-N-(4-chloro-2-((isopropylamino)meth-
yl)6-methylphenyl)-1-(3-chloropyridin-2-yl)-1H-py-
razole-5-carboxamide hydrochloride (9b)
White
1
solid, quantitative yield, m.p. 163—165 ℃; H NMR
(CDCl3, 400 MHz) δ: 9.97 (s, 1H, CONH), 9.15 (br s,
2H, NH+2 Cl- ), 8.45 (d, J=3.6 Hz, 1H, Ar-H), 7.84 (d,
J=7.6 Hz, 1H, Ar-H), 7.55 (s, 1H, Ar-H), 7.38—7.34
(m, 2H, Ar-H), 7.27 (s, 1H, Ar-H), 3.82 (s, 2H, CH2),
3.10 (s, 1H, CH), 2.23 (s, 3H, Ar-CH3), 1.18 (d, J=6.4
Hz, 6H, CH(CH3)2); 13C NMR (CDCl3, 100 MHz) δ:
155.8, 148.4, 147.2, 139.4, 139.3, 138.8, 133.2, 131.8,
131.6, 130.8, 128.8, 127.8, 126.9, 126.7, 111.3, 50.4,
43.4, 18.5, 17.8; HRMS calcd for C20H21BrCl2N5O ([M
-Cl])+496.0305, found 496.0301.
3-Bromo-N-(4-chloro-2-methyl-6-(thiazolidin-2-
yl)phenyl)-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-
carboxamide (11) To a solution of compound 7
(0.17g, 0.37 mmol) and 2-mercaptoethylamine hydro-
chloride (0.084 g, 0.74 mmol) in 20 mL of ethanol, po-
tassium acetate (0.073 g, 0.74 mmol) was added in one
portion. The resulting suspension was stirred at room
temperature for 12 h, and then most of the solvent was
removed in vacuum. The residue was dissolved in 50
mL of ethyl acetate, washed with water and brine. The
ethyl acetate solution was evaporated and then subjected
to flash chromatography using petroleum ether/ethyl
acetate (2/1, V/V) as the eluant to give the title com-
pound as white solid, yield 67.7%, m.p. 177—179 ℃;
1H NMR (CDCl3, 400 MHz) δ: 9.33 (s, 1H, CONH),
8.44 (d, J=4.4 Hz, 1H, Ar-H), 7.87 (d, J=8.4 Hz,
Ar-H), 7.51 (s, 1H, Ar-H), 7.37 (dd, J=4.8, 8.0 Hz, 1H,
Ar-H), 7.19 (s, 1H, Ar-H), 6.92 (s, 1H, Ar-H), 5.56 (s,
1H, CH), 3.39—3.33 (m, 1H, CH), 3.24—3.18 (m, 1H,
CH), 3.11—3.06 (m, 1H, CH), 3.01—2.96 (m, 1H, CH),
2.19 (s, 3H, Ar-CH3); 13C NMR (CDCl3, 100 MHz) δ:
155.4, 148.7, 146.8, 139.5, 139.2, 137.9, 135.7, 132.5,
131.9, 130.8, 128.8, 128.1, 126.5, 125.8, 110.2, 70.2,
51.6, 35.5, 18.6; HRMS calcd for C19H17BrCl2N5OS
([M+H]+) 511.9718, found 511.9709.
N-(2-((tert-Butylamino)methyl)-4-chloro-6-methyl-
phenyl)-3-bromo-1-(3-chloropyridin-2-yl)-1H-pyra-
zole-5-carboxamide hydrochloride (9c) White solid,
quantitative yield, m.p. 268—271 ℃; 1H NMR (CDCl3,
400+MHz) δ: 10.94 (s, 1H, CONH), 9.01 (br s, 2H,
NH2 Cl- ), 8.51 (d, J=4.0 Hz, 1H, Ar-H), 8.20 (d, J=
8.0 Hz, 1H, Ar-H), 7.77 (s, 1H, Ar-H), 7.63 (dd, J=4.8,
8.0 Hz, 1H, Ar-H), 7.56 (s, 1H, Ar-H), 7.49 (s, 1H,
Ar-H), 3.97 (s, 2H, CH2), 2.16 (s, 3H, Ar-CH3), 1.37 (s,
9H, C(CH3)3); 13C NMR (CDCl3, 100 MHz) δ: 155.7,
148.4, 147.1, 139.5, 139.3, 138.7, 133.5, 131.7, 131.6,
130.9, 129.5, 127.8, 126.9, 126.7, 111.1, 57.4, 40.5,
25.0, 17.7; HRMS calcd for C21H23BrCl2N5O ([M-Cl])+
510.0454, found 510.0458.
(Z)-3-Bromo-N-(4-chloro-2-((hydroxyimino)meth-
yl)-6-methylphenyl)-1-(3-chloropyridin-2-yl)-1H-
pyrazole-5-carboxamide (10a)
Hydroxylamine
hydrochloride (0.30 mmol) was added to a solution of
compound 7 (0.15 mmol) in 10 mL pyridine. After stir-
ring for 12 h at room temperature, ethyl acetate (50 mL)
was added. The mixture was washed with 2 mol/L hy-
drochloric acid, saturated sodium bicarbonate solution
and brine successively. After dried and evaporated, the
title compound was obtained as white solid. Yield 98%,
m.p. 172—174 ℃; 1H NMR (CDCl3, 400 MHz) δ: 9.15
(s, 1H, CONH), 8.44 (dd, J=1.2, 4.8 Hz, 1H, Ar-H),
8.32 (s, 1H, OH), 8.05 (s, 1H, CH), 7.87 (dd, J=1.0, 8.2
Biological activity
The insecticidal activities of compounds 5—11 and
chlorantraniliprole were evaluated using the reported
procedure.11 The insecticidal activity against oriental
armyworm was tested by foliar application, individual
corn leaves were placed on moistened pieces of filter
paper in Petri dishes. The leaves were then sprayed with
the test solution and allowed to dry. Then every 10
fourth-instar oriental armyworm larvae were put into
1654
© 2011 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Chin. J. Chem. 2011, 29, 1651— 1655